| Literature DB >> 31886174 |
Han Wang1, Ziming Liu2, Yuwan Li1,3, Yihang Peng4, Wei Xu1, Ning Hu1, Wei Huang1.
Abstract
PURPOSE: This is a systematic review and meta-analysis of current evidence that aims at comparing the clinical outcomes of remnant-preserving anterior cruciate ligament reconstruction (ACLR) and standard ACLR.Entities:
Mesh:
Year: 2019 PMID: 31886174 PMCID: PMC6927015 DOI: 10.1155/2019/1652901
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Distributions of factors related to final results within studies.
| Study | Time from injury to surgery (mo) | Pattern of ACL rupture | Amount of remnant | Type of graft | Procedure |
|---|---|---|---|---|---|
| Pujol et al [ | Group R: 4.5 | Group R: partial | Length: bridging femur and tibia in group R | Group R: auto | Group R: selective-bundle augmentation |
|
| |||||
| Zhang et al. [ | Group R: 12.7 | Group R: complete | Diameter: intact tibial remnant observed in both groups | Group R: auto | Group R: standard ACLR + tibial remnant sparing |
|
| |||||
| Demirag et al. [ | Group R: 2.3 | Group R: partial | Length: bridging femur and tibia in both groups | Group R: auto | Group R: selective-bundle augmentation |
|
| |||||
| Gohil et al. [ | Group R: 1.9 | NA | NA | Group R: auto | Group R: standard ACLR + tibial remnant sparing |
|
| |||||
| Lu et al. [ | Group R: 0.8 | Group R: complete | Length: bridging femur and tibia in group R | Group R: auto | Group R: standard ACLR + tibial remnant tensioning |
|
| |||||
| Hong et al. [ | Group R: 10.3 | Group R: complete | Length: able to be pulled into femoral tunnel and in both groups | Group R: allo | Group R: standard ACLR + tibial remnant tensioning |
|
| |||||
| Naraoka et al. [ | NA | NA | Length: >25% of native ACL in group R | Group R: auto | Group R: standard ACLR + tibial remnant tensioning |
|
| |||||
| Nakayama et al. [ | Group R: 12 | Group R: complete | Diameter: ≥50% of native ACL in group R | Group R: auto | Group R: standard ACLR + tibial remnant tensioning |
|
| |||||
| Kondo et al. [ | Group R: 7 | Group R: complete | Length: bridging femur and tibia in group R | Group R: auto | Group R: standard ACLR + tibial remnant tensioning |
|
| |||||
| Chen et al. [ | Group R: 16.5 | Group R: complete | NA | Group R: LARS | Group R: standard ACLR + tibial remnant sparing |
|
| |||||
| Rushton et al. [ | <3 mo: R 21, C 16 | Group R: complete + partial | NA | Group R: auto | Group R: standard ACLR + tibial remnant sparing |
Allo, allograft; auto, autograft; R, remnant; C, control; NA, not available; mo, month; LARS, Ligament Augmentation Reinforcement System.
Distributions of factors related to final results within studies.
| Study | Number of patients | Follow-up (mo) | Outcome measure | Results | Complications | Conclusion |
|---|---|---|---|---|---|---|
| Pujol et al [ | Group R: 29 | Group R: 12 | IKDC, Lysholm, KOOS, Rolimeter® knee tester | IKDC, Lysholm, and KOOS improved in both groups | Cyclops lesions: 1 in group R | No difference in functional scores between groups |
|
| ||||||
| Zhang et al. [ | Group R: 27 | Group R: 24.4 | Lysholm, KT-1000 knee arthrometer | Lysholm and KT-1000 improved in both groups | NA | No difference in functional score and joint stability between groups |
|
| ||||||
| Demirag et al. [ | Group R: 20 | Group R: 24.3 | IKDC and Lysholm | IKDC and Lysholm improved in both groups | Flexion loss: 7 in each group | No differences in functional scores between groups |
|
| ||||||
| Gohil et al. [ | Group R: 24 | Group R: 12 | IKDC, KT-1000 knee arthrometer | IKDC and KT-1000 improved in both groups | Extension loss: 2 in each group | Earlier revascularization in group R than in group C |
|
| ||||||
| Lu et al. [ | Group R: 36 | Group R: 34.7 | IKDC, Lysholm, Tegner, KT-2000 knee arthrometer | Better outcomes of IKDC, Lysholm, and KT-2000 in group R than in group C | Knee instability: 2 in group C | Faster ROM recovery, higher subjective outcome scores, and better second-look arthroscopy in group R than in group C |
|
| ||||||
| Hong et al. [ | Group R: 39 | Group R: 25.8 | IKDC, Lysholm, KT-1000 knee arthrometer | IKDC, Lysholm, and KT-1000 improved in both groups | Cyclops lesions: 3 in each group | No differences in stability, functional scores, revascularization, and proprioceptive outcomes between groups |
|
| ||||||
| Naraoka et al. [ | Group R: 77 | Group R: 24 | Lysholm, KT-1000 knee arthrometer | Lysholm and KT-1000 improved in both groups | Rerupture: 5 in group R and 6 in group C | No difference in stability and graft incorporation between groups |
|
| ||||||
| Nakayama et al. [ | Group R: 50 | Group R: 12 | Heel height difference, Lysholm, KT-1000 knee arthrometer | Lysholm and KT-1000 improved in both groups | Extension loss: 6 in group R and 3 in group C | Better tissue healing but higher incidence of extension loss in group R than in group C |
|
| ||||||
| Kondo et al. [ | Group R: 81 | Group R: 24 | IKDC, Lysholm, KT-2000 knee arthrometer | No difference in IKDC and 3D-CT between groups | Cyclops lesions: 9 in group R and 8 in group C (no symptoms) | Postoperative knee stability significantly improved in group R |
|
| ||||||
| Chen et al. [ | Group R: 38 | Group R: 120.8 | IKDC, Lysholm, KOOS, Tegner | Better scores of IKDC, Lysholm, KOOS, and Tegner in group R than in group C at 6 mo postoperatively | Screw-related problem: 3 in R and 2 in C | Earlier symptom relief and restoration of function in group R than in group C |
|
| ||||||
| Rushton et al. [ | Group R: 45 | Group R: 12 | IKDC, KT-2000 knee arthrometer | IKDC improved in both groups | Cyclops lesions:1 in group R | Better knee stability and quality of life in group R than in group C |
R, remnant; C, control; NA, not available; IKDC, International Knee Documentation Committee; KOOS, Knee Injury and Osteoarthritis Outcome Score.
Figure 1Flowchart of articles during the selection process.
Study features.
| Study | Publication year | Country | Type of study | Level of evidence | CMS score |
|---|---|---|---|---|---|
| Pujol et al. [ | 2012 | France | Randomized controlled trial | I | 79 |
| Zhang et al. [ | 2012 | China | Randomized controlled trial | I | 89 |
| Demirag et al. [ | 2012 | Turkey | Randomized controlled trial | I | 87 |
| Gohil et al. [ | 2007 | Australia | Randomized controlled trial | I | 91 |
| Lu et al. [ | 2015 | China | Randomized controlled trial | II | 92 |
| Hong et al. [ | 2012 | China | Randomized controlled trial | II | 92 |
| Naraoka et al. [ | 2017 | Japan | Prospective cohort study | II | 87 |
| Nakayama et al. [ | 2017 | Japan | Prospective cohort study | II | 84 |
| Kondo et al. [ | 2015 | Japan | Prospective cohort study | II | 77 |
| Chen et al. [ | 2012 | China | Prospective cohort study | II | 87 |
| Rushton et al. [ | 2012 | Canada | Prospective cohort study | II | 79 |
CMS score, the modified Coleman methodology score.
Detailed CMS for included studies.
| Study | Publication year | Study size | Mean follow-up | Number of procedures | Type of study | Diagnostic certainty | Surgery description | Rehabilitation description | Outcome criteria | Procedure for outcome | Selection process | Total score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pujol et al. [ | 2012 | 7 | 2 | 10 | 15 | 5 | 3 | 0 | 10 | 12 | 15 | 79 |
| Zhang et al. [ | 2012 | 7 | 5 | 10 | 15 | 5 | 5 | 10 | 10 | 12 | 10 | 89 |
| Demirag et al. [ | 2012 | 4 | 5 | 10 | 15 | 5 | 5 | 0 | 10 | 12 | 15 | 87 |
| Gohil et al. [ | 2007 | 7 | 2 | 10 | 15 | 5 | 5 | 10 | 10 | 12 | 15 | 91 |
| Lu et al. [ | 2015 | 10 | 5 | 10 | 10 | 5 | 5 | 10 | 10 | 12 | 15 | 92 |
| Hong et al. [ | 2012 | 10 | 5 | 10 | 15 | 5 | 5 | 10 | 10 | 12 | 10 | 92 |
| Naraoka et al. [ | 2017 | 10 | 5 | 10 | 10 | 5 | 5 | 10 | 10 | 12 | 10 | 87 |
| Nakayama et al. [ | 2017 | 10 | 2 | 10 | 10 | 5 | 5 | 10 | 10 | 12 | 10 | 84 |
| Kondo et al. [ | 2015 | 10 | 5 | 10 | 10 | 5 | 5 | 0 | 10 | 12 | 10 | 77 |
| Chen et al. [ | 2012 | 10 | 5 | 10 | 10 | 5 | 5 | 10 | 10 | 12 | 10 | 87 |
| Rushton et al. [ | 2012 | 10 | 2 | 10 | 10 | 5 | 5 | 0 | 10 | 12 | 15 | 79 |
Descriptions of 3 different remnant preservation techniques.
| Tibial remnant tensioning [ | Selective-bundle augmentation [ | Tibial remnant sparing [ |
|---|---|---|
| Several sutures of the remnant ACL were placed near the proximal end. | When the ACL remnant was attached to the anteroinferior portion of the anatomic femoral origin and the posterolateral (PL) bundle was well preserved, the anteromedial (AM) bundle was reconstructed. | The tibial tunnel position was within the boundaries of the ACL tibial remnant. |
|
| ||
| Medial traction of these sutures provided a wide view during the reconstruction. | When the ACL remnant was attached to the high-noon position with a well-preserved AM bundle, the PL bundle was reconstructed. | The ACL graft was allowed to pass through the tibial tunnel within the tibial remnant. |
|
| ||
| Fixation was performed with a slightly smaller tension with the tibial remnant from the femoral tunnel. | ||
Figure 2Forest plot for Lysholm scores. CI: confidence interval; IV: inverse variance.
Figure 3Forest plot for IKDC subject scores. CI: confidence interval; IV: inverse variance.
Figure 4Forest plot for IKDC grades. CI: confidence interval; MH: Mantel–Haenszel.
Figure 5Forest plot for arthrometer measurements. CI: confidence interval; IV: inverse variance.
Figure 6Forest plot for Lachman test. CI: confidence interval; MH: Mantel–Haenszel.
Figure 7Forest plot for pivot-shift test. CI: confidence interval; MH: Mantel–Haenszel.
Figure 8Forest plot for second-look arthroscopic evaluation. CI: confidence interval; MH: Mantel–Haenszel.
Figure 9Forest plot for complication incidence. CI: confidence interval; MH: Mantel–Haenszel.